5 Matching Annotations
  1. Last 7 days
    1. Patient 2 (P2), previously described in a large IRD cohort study [1], is also of Somali origin and was seen in the retina clinic at the University of Iowa at age 11

      Case#: patient, 11, Somali, onset 8yo

      DiseaseAssertion: STGD

      FamilyInfo: parents and four siblings did not report visual issues

      CasePresentingHPOs: HP:0000007, HP:0011504, HP:0000608

      CaseHPOFreeText: BCVA 20/70 OD, 20/80 OS. Bull's eye maculopathy. Outer retinal and RPE atrophy. Slight opacity at level of RPE; loss of outer retinal structures in central area. Normal peripheral retina.

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: n/a

      Genotyping Method: whole genome

      PreviouslyPublished: PMID:28559085

      Variant: NM_000350.3:c.5882G>A p.(Gly1961Glu) ; NM_000350.3:c.634C>T p.(Arg212Cys)

      ClinVar:7888; 7898

      CAID:n/a

      SupplementalData:n/a

    2. Patient 1 (P1) experienced reduced vision from age 5 and was referred to ophthalmology testing at Haukeland University Hospital at age 12.

      Case#: patient, 12, Somali, onset 5yo

      DiseaseAssertion: STGD

      FamilyInfo: parents and 5 siblings did not report visual issues

      CasePresentingHPOs: HP:0000007, HP:0011504, HP:0000608

      CaseHPOFreeText: BCVA 20/135 OD; 20/100 OS. Red-green color deficit. Bull's eye maculopathy, but no pallor of optic disc. Normal peripheral retina. Loss of macular photoreceptor layer; severely reduced cone function.

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: n/a

      Genotyping Method: whole exome sequencing

      PreviouslyPublished: n/a

      Variant: NM_000350.3:c.5882G>A p.(Gly1961Glu) ; NM_000350.3:c.634C>T p.(Arg212Cys)

      ClinVar: 7888; 7898

      CAID: n/a

      SupplementalData: n/a

    1. A 25‐year‐old male presented to our hospital with a chief complaint of blurred vision in the right eye and significant night vision difficulties (nyctalopia) for 5 years.

      Case#:patient, 25, male

      DiseaseAssertion:Retinitis Pigmentosa

      FamilyInfo:Unaffected brother with no variants, parents each heterozygous for one pathogenic variant in ABCA4

      CasePresentingHPOs: HP:0000007, HP:0011462, HP:0007703, HP:0000662, HP:0007641

      CaseHPOFreeText: Onset 20 year old. Gradual onset of blurred vision OD, dyschromatopsia. BCVA 1/20 OD 20/20 OS. Optic disc pale, retinal arteries and foveal reflex attenuated. Yellow deposits in perofoveal area and mid-peripheral retina, which showed mottled appearance OU. OCT - thinning of outer nuclear layer and disruption of ellipsoid zone with hyper-reflective flecks. Severe bilateral constriction in visual field. Hypofluorescence of optic disc OU

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: n/a

      Genotyping Method: whole exome (Sanger segregation test)

      PreviouslyPublished: n/a

      Variant: NM_000350.3:c.4793C>A; NM_000350.3:c.1769A>G

      ClinVar: 99321

      CAID: CA341279788

      SupplementalData: n/a

    1. An eight year-old Hispanic female

      Case#: An 8-year old Hispanic female

      DiseaseAssertion: Whole exome sequencing identified a homozygous ABCA4 missense variant (p.Arg602Trp) that has been identified as a Stargardt Disease mutation

      FamilyInfo: consanguinity, her parents being first cousins, no family history of blindness. Familial cosegregation analysis was used, with both parents being heterozygous carriers.

      CasePresentingHPOs: HP:0000529, HP:0000662, HP:0000556, HP:0002017,HP:0008046, HP:0031528, HP:0003678

      CaseHPOFreeText: rapidly progressive vision loss, nyctalopia and retinal dystrophy, bilateral decreased vision following a febrile gastrointestinal illness with nausea and vomiting, Initial visual acuity was 20/60 at distance and 20/30 at near in both eyes, after 2 years visual acuities of 20/200 at distance in both eyes, attenuated vessels and multiple subretinal blister-like elevations, Cycloplegic retinoscopy detected very mild hyperopia and astigmatism in both eyes (OD: + 1.00 sphere + 1.00 cylinder axis 110 degrees; OS: + 0.75 sphere + 0.50 cylinder axis 60 degrees)

      CaseNotHPOs: NR

      CaseNotHPOFreeText: no evidence of a diffuse post-infectious/inflammatory process

      Genotyping Method: DNA analysis by whole exomic sequencing

      PreviouslyPublished: No

      Variant: NM_000350.3:c.1804C>T

      ClinVar:99084

      CAID:CA226932

      SupplementalData:

    1. Case report: Disease phenotype associated with simultaneous biallelic mutations in ABCA4 and USH2A due to uniparental disomy of chromosome 1

      Case#: Patient 9, female, Mexican, symptoms onset 6 yrs. ago, Mexico City

      DiseaseAssertion: IRD

      FamilyInfo: parents are non-sanguineous and asymptomatic, they also denied any history related to ocular diseases. Information disclosed that the mother had one stillbirth and three miscarriages, but denied any related diseases/health issues to this child.

      CasePresentingHPOs: HP:00305, HP:00080, HP:0000493, HP:0025586, HP:0030329, HP:0012713

      CaseHPOFreeText: Proband presented with light sensitivity as well as adaptation difficulties when going from dark-to-light. Right eye was 20/200 and left eye was 20/160 from the visual acuity test. Macular bull's eye appearance. Subnormal rod and cone responses. Peripapillary sparing retina.

      CaseNotHPOs: HP:0007737, HP:0000750, HP:0000510

      CaseNotHPOFreeText: No afferent pupillary defect. No anomalies in anterior segment.

      Genotyping Method: QIAamp DNA Blood Kit was used to extract gDNA and quantification/purity of the sample was found using a NanoDrop 2000 spectrophotometer. 293 genes were sequenced. gDNA was sequenced via Illumina technology. Following, certain sequences were additionally analyzed against a reference genome in order to identify changes and interpret.

      PreviouslyPublished: n/a

      Variant: NM_000350.3(ABCA4):c.4926C>G (p.Ser1642Arg), NM_000350.3(ABCA4):c.5044_5058del (p.Val1682_Val1686del)

      ClinVar: 99332, 99340

      CAID: n/a

      SupplementalData: Phenotype data in results section as well as figures 1, 2, and 3 showing phenotypic testing results.